Mebias-Discovery,-LLC-logo

Mebias Discovery, LLC

Mebias Discovery, LLC discovers and progresses pathway selective GPCR drugs. It offers GPCR targets for neurodegenerative disorders, mood disorders, pain (non-opioid), cardiovascular, and immuno-oncology.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://mebiasdiscovery.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
Address
3025 Market Street, Suite 140,PA,19104
Philadelphia
United States
Email
Contact Number
+1 267-536-4125

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/mebias-discovery” connections=”true” suffix=””]